Publications

Export 7 results:
Sort by: Author Title Type [ Year (Desc)]
Filters: Keyword is Drug Administration Schedule  [Clear All Filters]
2012
Mega JL, Braunwald E, Wiviott SD, Bassand J-, Bhatt DL, Bode C, et al. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med. 2012;366(1):9-19. Abstract
Mega JL, Braunwald E, Wiviott SD, Bassand J-, Bhatt DL, Bode C, et al. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med. 2012;366(1):9-19. Abstract
2010
Macintyre IM, Dhaun N, Lilitkarntakul P, Melville V, Goddard J, Webb DJ. Greater functional ETB receptor antagonism with bosentan than sitaxsentan in healthy men. Hypertension. 2010;55(6):1406-11. Abstract
Schopman JE, Geddes J, Frier BM. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. Diabetes Res Clin Pract. 2010;87(1):64-8. Abstract
2009
Collet J-, Montalescot G, Steg PG, Steinhubl SR, Fox KA, Hu T, et al. Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial. Arch Cardiovasc Dis. 2009;102(6-7):485-96. Abstract
2004
Crockett TR, Gray GA, Kane KA, Wainwright CL. Sarafotoxin 6c (S6c) reduces infarct size and preserves mRNA for the ETB receptor in the ischemic/reperfused myocardium of anesthetized rats. J Cardiovasc Pharmacol. 2004;44(2):148-54. Abstract
2002
Drake AJ, Howells RJ, Shield JP, Prendiville A, Ward PS, Crowne EC. Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ. 2002;324(7345):1081-2.